nach oben

Journal of Neural Transmission

Erschienen in:

01.05.2012 | Biological Psychiatry - CONy Pro/Con debate

Where does a migraine attack originate? In the brainstem

verfasst von: J. Tajti, D. Szok, Á. Párdutz, B. Tuka, A. Csáti, A. Kuris, J. Toldi, L. Vécsei

Erschienen in: Journal of Neural Transmission | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Migraine is a common, paroxysmal, highly disabling primary headache disorder. The origin of migraine attacks is enigmatic. Numerous clinical and experimental results suggest that the activation of distinct brainstem nuclei is crucial in its pathogenesis, but the primary cause of this activation is not fully understood. We conclude that the initialization of a migraine attack can be explained as an altered function of the neuronal elements of the brainstem nuclei. In light of our findings and the literature data, we can assume that migraine is a subcortical disorder of a specific brainstem area.

Afridi SK, Goadsby PJ (2003) New onset migraine with a brainstem cavernous angioma. J Neurol Neurosurg Psychiatry 74:680–682PubMedCrossRef

Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RSJ, Goadsby PJ (2005) A positron emission tomographic study in spontaneous migraine. Arch Neurol 62:1270–1275PubMedCrossRef

Akerman S, Goadsby PJ (2009) VPAC₁ and PAC₁ receptor antagonists inhibit activation of the parasympathetic outflow to the cranial vasculature to prevent autonomic responses and neuronal firing in the trigeminocervical complex. Cephalalgia 29(Suppl. 1):130

Akerman S, Holland PR, Lasalandra MP, Goadsby PJ (2009) Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Headache 49:1131–1143PubMedCrossRef

Amaral DG, Sinnamon HM (1977) The locus coeruleus: neurobiology of a central noradrenergic nucleus. Prog Neurobiol 9:147–196PubMedCrossRef

Ambrosini A, De Pasqua V, Afra J, Sandor PS, Schoenen J (2001) Reduced gating of middle-latency auditory evoked potentials (P50) in migraine patients: another indication of abnormal sensory processing? Neurosci Lett 306:132–134PubMedCrossRef

Aurora SK, Barrodale PM, Tipton RL, Khodavirdi A (2007) Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache 47:996–1003PubMedCrossRef

Avramidis TG, Podikoglu DG, Anastasopoulos IE, Koutroumanidis MA, Papadimitriou AL (1998) Blink reflex in migraine and tension-type headache. Headache 38:691–696PubMedCrossRef

Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ (2001) Brainstem activation specific to migraine headache. Lancet 357:1016–1017PubMedCrossRef

Bánk J, Bense E, Király C (1992) The blink reflex in migraine. Cephalalgia 12:289–292PubMedCrossRef

Barbanti P, Fabbrini G, Pesare M, Vanacore N, Cerbo R (2002) Unilateral cranial autonomic symptoms in migraine. Cephalalgia 22:256–259PubMedCrossRef

Barbanti P, Fabbrini G, Vanacore N, Pesare M, Buzzi MG (2003) Sumatriptan in migraine with unilateral cranial autonomic symptoms: an open study. Headache 43:400–403PubMedCrossRef

Bartsch T, Goadsby PJ (2002) Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 125:1496–1509PubMedCrossRef

Bartsch T, Goadsby PJ (2003) Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 126:1801–1813PubMedCrossRef

Bartsch T, Goadsby PJ (2005) Anatomy and physiology of pain referral patterns in primary and cervicogenic headache disorders. Headache Currents 2:42–48CrossRef

Bartsch T, Knight YE, Goadsby PJ (2004) Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 56:371–381PubMedCrossRef

Basbaum AJ, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann Rev Neurosci 7:309–338PubMedCrossRef

Basbaum AJ, Clanton CH, Fields HL (1978) Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain-modulating systems. J Comp Neurol 178:209–224PubMedCrossRef

Beadle GW, Mitchell HK, Nyc JF (1947) Kynurenine as an intermediate in the formation of nicotinic acid from tryptophane by neurospora. Proc Natl Acad Sci USA 33:155–158PubMedCrossRef

Behan WM, McDonald M, Darlington LG, Stone TW (1999) Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 128:1754–1760PubMedCrossRef

Bernays RL, Heeb L, Cuenod M, Streit P (1988) Afferents to the rat red nucleus studied by means of D[3H]aspartate, [3H]choline and non-selective tracers. Neuroscience 26:601–619PubMedCrossRef

Bertolino M, Vicini S, Costa E (1989) Kynurenic acid inhibits the activation of kainic and N-methyl-d-aspartic acid-sensitive ionotropic receptors by a different mechanism. Neuropharmacol 28:453–457CrossRef

Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol 151:313–315PubMedCrossRef

Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136–142PubMedCrossRef

Bouchelet I, Cohen Z, Case B, Seguela P, Hamel E (1996) Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 50:219–223PubMed

Bruinvels AT, Landwehrmeyer B, Gustafson EL (1994) Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacol 33:367–386CrossRef

Brun P, Suaud-Chagny MF, Lachuer J, Gonon F, Buda M (1991) Catecholamine metabolism in locus coeruleus neurons: a study of its activation by sciatic nerve stimulation in the rat. Eur J Neurosci 3:397–406PubMedCrossRef

Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–982PubMed

Burstein R, Cutrer MF, Yarnitsky D (2000a) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709PubMedCrossRef

Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000b) An association between migraine and cutaneous allodynia. Ann Neurol 47:614–624PubMedCrossRef

Cao Y, Welch KM, Aurora S, Vikingstad EM (1999) Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 56:548–554PubMedCrossRef

Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM (2002) Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 59:72–78PubMed

Chan KY, Baun M, de Vries R, van den Bogaerdt AJ, Dirven CM, Danser AH, Jansen-Olesen I, Olesen J, Villalón CM, MaassenVanDenBrink A, Gupta S (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31:181–189PubMedCrossRef

Chiang CY, Hu JW, Sessle BJ (1997) NMDA receptor involvement in neuroplastic changes induced by neonatal capsaicin treatment in trigeminal nociceptive neurons. J Neurophysiol 78:2799–2803PubMed

Coderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665–3670PubMed

Coppola G, Currà A, Sava SL, Alibardi A, Parisi V, Pierelli F, Schoenen J (2010) Changes in visual-evoked potential habituation induced by hyperventilation in migraine. J Headache Pain 11:497–503PubMedCrossRef

Craig PJ, McAinsh AD, McCormack AL, Smith W, Beattie RE, Priestley JV, Yip JLY, Averill S, Longbottom ER, Volsen SG (1998) Distribution of the voltage-dependent calcium channel α(1A) subunit throughout the mature rat brain and its relationship to neurotransmitter pathways. J Comp Neurol 397:251–267PubMedCrossRef

Cropper EC, Eisenman JS, Azmitis EC (1984) 5-HT-immunoreactive fibers in the trigeminal nuclear complex of the rat. Exp Brain Res 55:515–522PubMedCrossRef

Cutrer FM (2010) Pathophysiology of migraine. Semin Neurol 33:120–130CrossRef

DaSilva AFM, Becerra L, Makris N (2002) Somatotopic activation in the human trigeminal pain pathway. J Neurosci 22:8183–8192PubMed

Davidoff RA (1995) Migraine: manifestations, pathogenesis and management. FA Davis Company, Philadelphia, pp 115–180

De Carvalho LP, Bochet P, Rossier J (1996) The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem Int 28:445–452PubMedCrossRef

De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G (2003) Haploinsufficiency of ATP1A2 encoding the Na⁺/K⁺ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192–196PubMedCrossRef

De Marinis M, Pujia A, Natale L, D’arcangelo E, Accornero N (2003) Decreased habituation of the R2 component of the blink reflex in migraine patients. Clin Neurophysiol 114:889–893PubMedCrossRef

De Marinis M, Pujia A, Colaizzo E, Accornero N (2007) The blink reflex in “chronic migraine”. Clin Neurophysiol 118:457–463PubMedCrossRef

De Tommaso M, Guido M, Libro G, Sciruicchio V, Puca F (2000) Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans. Neurosci Lett 289:57–60PubMedCrossRef

De Tommaso M, Murasecco D, Libro G, Guido M, Sciruicchio V, Specchio LM et al (2002) Modulation of trigeminal reflex excitability in migraine: effects of attention and habituation on the blink reflex. Int J Psychophysiol 44:239–249PubMedCrossRef

De Tommaso M, Sardaro M, Pecoraro C, Di Fruscolo O, Serpino C, Lamberti P, Livrea P (2007) Effects of the remote C fibres stimulation induced by capsaicin on the blink reflex in chronic migraine. Cephalalgia 27:881–890PubMedCrossRef

Del Rio MS, Linera JA (2004) Functional neuroimaging of headaches. Lancet Neurol 3:645–651CrossRef

Demarquay G, Lothe A, Royet JP, Costes N, Mick G, Mauguiére F, Ryvlin P (2011) Brainstem changes in 5-HT1A receptor availability during migraine attack. Cephalalgia 31:84–94PubMedCrossRef

Di Clemente L, Coppola G, Magis D, Fumal A, De Pasqua V, Di Piero V, Schoenen J (2007) Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? Brain 130:765–770PubMedCrossRef

Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371–377PubMedCrossRef

Dickson L, Finlayson K (2009) VPAC and PAC receptors: from ligands to function. Pharmacol Ther 121:294–316PubMedCrossRef

Diener HC (1997) Positron emission tomography studies in headache. Headache 37:622–625PubMedCrossRef

Diener HC (1999) How can PET scans help us understand headache mechanisms? Cephalalgia 23:15–18

Diener HC, May A (1996) Positron emission tomography studies in acute migraine attacks. In: Sandler M, Ferrari M, Harnett S (eds) Migraine: pharmacology and genetics. Chapman and Hall, London, pp 109–116

Dodick D, Silberstein S (2006) Central sensitization theory of migraine: clinical implications. Headache 46:S182–S191PubMedCrossRef

Dykens JA, Sullivan SG, Stern A (1987) Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochem Pharmacol 36:211–217PubMedCrossRef

Eastman CL, Guilarte TR (1990) The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine. Neurochem Res 15:1101–1107PubMedCrossRef

Edvinsson L, Goadsby PJ (1995) Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 15:272–276PubMed

Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Rev 48:438–456PubMedCrossRef

Ennis M, Aston-Jones G (1988) Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J Neurosci 8:3644–3657PubMed

Ennis M, Aston-Jones G, Shiekhattar R (1992) Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. Brain Res 598:185–195PubMedCrossRef

Ferrari MD (2005) Migraine as an ion-transporter disorder. Cephalalgia 25:842CrossRef

Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW (1989) Serotonin metabolism in migraine. Neurology 39:1239–1242PubMed

Fields HL (1994) Pain modulation and the action of analgesic medications. Ann Neurol 35:S42–S45PubMedCrossRef

Fields HL, Basbaum AI (1999) Central nervous system mechanisms of pain modulation. In: Wall PED, Melzack R (eds) Textbook of pain. Churchill Livingstone, Edinburgh

Gigler G, Szenasi G, Simo A, Levay G, Harsing LG Jr, Sas K (2007) Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils. Eur J Pharmacol 564:116–122PubMedCrossRef

Goadsby PJ (1998) A triptan too far? J Neur Neurosurg Psych 64:143–147CrossRef

Goadsby PJ (2002) Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 22:107–111PubMedCrossRef

Goadsby PJ (2005) Migraine, allodynia, sensitisation and all of that. Eur Neurol 53:10–16PubMedCrossRef

Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346:257–270PubMedCrossRef

Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG (2009) Tonabersat TON-01-05 Study Group. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia 7:742–750CrossRef

Gobaille S, Kemmel V, Brumaru D, Dugave C, Aunis D, Maitre M (2008) Xanthurenic acid distribution, transport, accumulation and release in the rat brain. J Neurochem 105:982–993PubMedCrossRef

Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713–716PubMedCrossRef

Guidetti P, Schwarcz R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11:3857–3863PubMedCrossRef

Guidetti P, Okuno E, Schwarcz R (1997) Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50:457–465PubMedCrossRef

Guidetti P, Amori L, Sapko MT, Okuno E, Schwarcz R (2007) Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem 102:103–111PubMedCrossRef

Guillemin GJ, Kerr SJ, Pemberton LA, Smith DG, Smythe GA, Armati PJ (2001) IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment. J Interf Cytokine Res 21:1097–1101CrossRef

Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105–112PubMedCrossRef

Guillemin GJ, Cullen KM, Lim CK, Smythe GA, Garner B, Kapoor V (2007) Characterization of the kynurenine pathway in human neurons. J Neurosci 27:12884–12892PubMedCrossRef

Gupta VK (2006) Brainstem activity in migraine: primary or secondary? Arch Neurol 63:1347PubMedCrossRef

Hadjikhani N, Sanchez del Rio M, Wu O (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98:4687–4692PubMedCrossRef

Hajos M, Engberg G (1990) A role of excitatory amino acids in the activation of locus coeruleus neurons following cutaneous thermal stimuli. Brain Res 521:325–328PubMedCrossRef

Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293–1300PubMedCrossRef

Hansen JM, Bolla M, Magis D, de Pasqua V, Ashina M, Thomsen LL, Olesen J, Schoenen J (2011) Habituation of evoked responses is greater in patients with familial hemiplegic migraine than in controls: a contrast with the common forms of migraine. Eur J Neurol 18:478–485PubMedCrossRef

Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24:1–160

Heyliger SO, Goodman CB, Ngong JM, Soliman KF (1998) The analgesic effects of tryptophan and its metabolites in the rat. Pharmacol Res 38:243–250PubMedCrossRef

Hillman D, Chen S, Aung TT, Cherksey B, Sugimori M, Llinas RR (1991) Localization of P-type calcium channels in the central nervous system. Proc Natl Acad Sci USA 88:7076–7080PubMedCrossRef

Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463–7473PubMed

Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev 6:573–582

Hopf HC (1994) Topodiagnostic value of brainstem reflexes. Muscle Nerve 17:475–484PubMedCrossRef

Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW (2008) Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain 4:54PubMedCrossRef

Jhamandas K, Boegman RJ, Beninger RJ, Bialik M (1990) Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites. Brain Res 529:185–191PubMedCrossRef

Jiang M, Behbehani MM (2001) Physiological characteristics of the projection pathway from the medial preoptic to the nucleus raphe magnus of the rat and its modulation by the periaqueductal gray. Pain 94:139–147PubMedCrossRef

Kalen P, Strecker RE, Rosengren E, Bjorklund A (1989) Regulation of striatal serotonin release by the lateral habenula-dorsal raphe pathway in the rat as demonstrated by in vivo microdialysis: role of excitatory amino acids and GABA. Brain Res 492:187–202PubMedCrossRef

Katsarava Z, Giffin N, Diener H-C, Kaube H (2003) Abnormal habituation of ‘nociceptive’ blink reflex in migraine—evidence for increased excitability of trigeminal nociception. Cephalalgia 23:814–819PubMedCrossRef

Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J, Diener H-C (2002) Acute migraine headache. Possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 58:1234–1238PubMed

Kerr FWL, Olafson RA (1961) Trigeminal and cervical volleys. Arch Neurol 5:69–76CrossRef

Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52:1319–1328PubMedCrossRef

Kimura J (1983) Electrodiagnosis in diseases of nerve and muscle: principles and practice. FA Davis Company, Philadelphia

Knight YE, Goadsby PJ (2001) The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience 106:793–800PubMedCrossRef

Knight YE, Bartsch T, Kaube H, Goadsby PJ (2002) P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci 22:RC213PubMed

Knyihar-Csillik E, Toldi J, Krisztin-Peva B, Chadaide Z, Nemeth H, Fenyo R (2007a) Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid. Neurosci Lett 418:122–126PubMedCrossRef

Knyihar-Csillik E, Toldi J, Mihaly A, Krisztin-Peva B, Chadaide Z, Nemeth H (2007b) Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. J Neural Transm 114:417–421PubMedCrossRef

Kors EE, Terwindt GM, Vermeulen F, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg A, Haan J, Frants RR, Ferrari MD (2001) Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 49:753–760PubMedCrossRef

Lambert GA, Zagami AS (2009) The mode of action of migraine triggers: a hypothesis. Headache 49:253–275PubMedCrossRef

Lance JW, Lambert GA, Goadsby PJ, Duckworth JW (1983) Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 23:258–265PubMedCrossRef

Lance JW, Lambert GA, Goadsby PJ, Zagami AS (1990) Contribution of experimental studies to understanding the pathophysiology of migraine. In: Sandler M, Collins GM (eds) Migraine: a spectrum of ideas. Oxford University Press, Oxford, pp 21–39

Lapin IP (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42:37–43PubMedCrossRef

Leao AAP (1944) Spreading depression of activity in cerebral cortex. J Neurophysiol 7:359–390

Levine ES, Jacobs BL (1992) Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat. J Neurosci 12:4037–4044PubMed

Levy D, Strassman AM, Burstein R (2009) A critical view on the role of migraine triggers in the genesis of migraine pain. Headache 49:953–957PubMedCrossRef

Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657PubMedCrossRef

Lovick TA, Wolstencroft JH (1983) Projections from brain stem nuclei to the spinal trigeminal nucleus in the cat. Neuroscience 9:411–420PubMedCrossRef

Martella G, Costa C, Pisani A, Cupini LM, Bernardi G, Calabresi P (2008) Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia 28:1315–1326PubMedCrossRef

Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ (2005) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128:932–939PubMedCrossRef

May A, Ophoff RA, Terwindt GM, Urban C, Vaneijk R, Haan J, Diener HC, Lindhout D, Frants RR, Sandkuijl LA, Ferrari Med (1995) Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet 96:604–608

May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ (1998) Hypothalamic activation in cluster headache. Lancet 352:275–278PubMedCrossRef

May A, Bahra A, Buchel C, Turner R, Goadsby PJ (1999) Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 46:791–794PubMedCrossRef

McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692–1696PubMedCrossRef

Messlinger K (2009) Migraine: when and how does the pain originate? Exp Brain Res 196:179–193PubMedCrossRef

Morgan MM, Bobeck EN, Ingram SL (2009) Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res 1295:59–66PubMedCrossRef

Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8:801–815PubMed

Murphy AZ, Behbehani MM (1993) Electrophysiological characterization of the projection from the nucleus raphe magnus to the lateral reticular nucleus: possible role of an excitatory amino acid in synaptic activation. Brain Res 606:68–78PubMedCrossRef

Neeb L, Meents J, Reuter U (2010) 5-HT1F receptor agonists: a new treatment option for migraine attacks? Neurotherapeutics 7:176–182PubMedCrossRef

Nieber K, Poelchen W, Illes P (1997) Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol 122:423–430PubMedCrossRef

Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR (1998) Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology 50:1428–1432PubMed

Obermann M, Yoon MS, Dommes P, Kuznetsova J, Maschke M, Weimar C, Limmroth V, Diener HC, Katsarava Z (2007) Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia 27:504–509PubMedCrossRef

Olpe HR, Steinmann MW, Brugger F, Pozza MF (1989) Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro study. Naunyn Schmiedebergs Arch Pharmacol 339:312–314PubMedCrossRef

Ophoff RA, Terwindt GM, Vergouwe MN, vanEijk R, Oefner PJ, Hoffman SMG, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, vanOmmen GJB, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca²⁺ channel gene CACNL1A4. Cell 87:543–552PubMedCrossRef

Oshinsky ML, Luo J (2006) Neurochemistry of trigeminal activation in an animal model of migraine. Headache 46:S39–S44PubMedCrossRef

Palkovits M, Jacobowitz DM (1974) Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon). J Comp Neurol 157:29–42PubMedCrossRef

Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J (2000) Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. NeuroReport 11:3071–3075PubMedCrossRef

Pardutz A, Hoyk Z, Varga H, Vecsei L, Schoenen J (2007) Oestrogen-modulated increase of calmodulin-dependent protein kinase II (CamKII) in rat spinal trigeminal nucleus after systemic nitroglycerin. Cephalalgia 27:46–53PubMedCrossRef

Pascual J, del Arco C, Romón T, del Olmo E, Castro E, Pazos A (1996) Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 16:317–322PubMedCrossRef

Ping HX, Wu HQ, Liu GQ (1990) Modulation of neuronal activity of locus coeruleus in rats induced by excitatory amino acids. Zhongguo Yao Li Xue Bao 11:193–195PubMed

Pinnock RD (1992) Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphe nucleus in vitro. Brain Res 583:237–246PubMedCrossRef

Piovesan EJ, Kowacs PA, Oshinsky ML (2003) Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep 7:377–383PubMedCrossRef

Politi V, Lavaggi MV, Di Stazio G, Margonelli A (1991) Indole-3-pyruvic acid as a direct precursor of kynurenic acid. Adv Exp Med Biol 294:515–518PubMed

Politi V, D’Alessio S, Di Stazio G, De Luca G (1996) Antioxidant properties of indole-3-pyruvic acid. Adv Exp Med Biol 398:291–298PubMedCrossRef

Prescott C, Weeks AM, Staley KJ, Partin KM (2006) Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402:108–112PubMedCrossRef

Raskin NH, Hosobuchi Y, Lamb S (1987) Headache may arise from perturbation of the brain. Headache 27:416–420PubMedCrossRef

Richter RC, Behbehani MM (1991) Evidence for glutamic acid as a possible neurotransmitter between the mesencephalic nucleus cuneiformis and the medullary nucleus raphe magnus in the lightly anesthetized rat. Brain Res 544:279–286PubMedCrossRef

Richter F, Rupprecht S, Lehmenkühler A, Schaible H-G (2003) Spreading depression can be elicited in brainstem in immature but not adult rats. J Neurophysiol 90:2163–2170PubMedCrossRef

Richter F, Lehmenkühler A, Schaible H-G (2005) Voltage-gated calcium channels are not involved in generation and propagation of spreading depression (SD) in the brainstem of immature rats. Neurosci Lett 390:15–20PubMedCrossRef

Richter F, Bauer R, Lehmenkühler A, Schaible HG (2008) Spreading depression in the brainstem of the adult rat: electrophysiological parameters and influences on regional brainstem blood flow. J Cereb Blood Flow Metab 28:984–994PubMedCrossRef

Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16:1139–1143PubMedCrossRef

Schoenen J (1997) Acute migraine therapy: the newer drugs. Curr Opin Neurol 10:237–243PubMedCrossRef

Schoenen J (2006) Neurophysiological features of the migrainous brain. Neurol Sci 27(Suppl 2):S77–S81PubMedCrossRef

Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R, Munz LD, Arnold G (2007) Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 254:789–796PubMedCrossRef

Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1–10PubMedCrossRef

Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16–25PubMedCrossRef

Sessle BJ, Hu JW, Dubner R, Lucier GE (1981) Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effect of naloxone. J Neurophysiol 45:193–207PubMed

Silberstein SD, Lipton RB, Goadsby PJ (1998) Headache in clinical practice. Isis Medical Media, Oxford, pp 41–90

Smith DH, Okiyama K, Thomas MJ, McIntosh TK (1993) Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J Neurosci 13:5383–5392PubMed

Sprenger T, Goadsby PJ (2010) What has functional neuroimaging done for primary headache and for the clinical neurologist? J Clin Neurosci 17:547–553PubMedCrossRef

Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle TR (2005) SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 113:422–426PubMedCrossRef

Stovner L, Hogen K, Jensen R, Katsarava Z, Lipton R, Scher A (2007) The global burden of headache: a documentation of headache prevalence and disability world-wide. Cephalalgia 27:193–210PubMedCrossRef

Tajti J, Uddman R, Edvinsson L (2001) Neuropeptide messengers in the migraine generator region of the human brainstem. Cephalalgia 21:96–101PubMedCrossRef

Tassorelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res 682:167–181PubMedCrossRef

Tavares RG, Tasca CI, Santos CE, Alves LB, Porciuncula LO, Emanuelli T (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40:621–627PubMedCrossRef

Tortorella P, Rocca MA, Colombo B, Annovazzi P, Comi G, Filippi M (2006) Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neur Sci 244:137–141CrossRef

Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr, Schwarcz R (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res 454:164–169PubMedCrossRef

Tyce GM (1990) Origin and metabolism of serotonin. J Cardiovasc Pharmacol 16(Suppl 3):S1–S7PubMed

Valentino RJ, Bey V, Pernar L, Commons KG (2003) Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J Neurosci 23:7155–7159PubMed

Vamos E, Pardutz A, Varga H, Bohar Z, Tajti J, Fulop F (2009) L-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacol 57:425–429CrossRef

Vamos E, Fejes A, Koch J, Tajti J, Fulop F, Toldi J (2010) Kynurenate derivative attenuates the nitroglycerin-induced CamKIIalpha and CGRP expression changes. Headache 50:834–843PubMedCrossRef

Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357PubMedCrossRef

Vecsei L, Miller J, MacGarvey U, Beal MF (1992) Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA—induced seizures and increase kynurenic acid concentrations in the brain. Brain Res Bull 28:233–238PubMedCrossRef

Veloso F, Kumar K, Toth C (1998) Headache secondary to deep brain implantation. Headache 38:507–515PubMedCrossRef

Waeber C, Moskowitz MA (1995) [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 352:263–275PubMedCrossRef

Wang XM, Mokha SS (1996) Opioids modulate N-methyl-d-aspartic acid (NMDA)-evoked responses of trigeminothalamic neurons. J Neurophysiol 76:2093–2096PubMed

Weiller C, May A, Limmorth V, Jüptner M, Kaube H, Schayck R, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658–660PubMedCrossRef

Welch KM, Cao Y, Aurora S, Wiggins G, Vikingstad EM (1998) MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 51:1465–1469PubMed

Welch KM, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRef

Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TVB, Snutch TP, Caterall WA (1995) Immunochemical identification and subcellular distribution of the α(1A) subunits of brain calcium channels. J Neurosci 15:6403–6418PubMed

Wise SP, Jones EG (1977) Cells of origin and terminal distribution of descending projections of the rat somatic sensory cortex. J Comp Neurol 175:129–157PubMedCrossRef

Wolf H (1974) The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand J Clin Lab Invest 136:1–186

World Health Organization (2001) The World Health Report 2001. WHO, Geneva

Yokota T (1988) Anatomy and physiology of intra- and extracranial nociceptive afferents and their central projections. In: Olesen J, Edvinsson L (eds) Basic mechanisms of headache. Elsevier, New York

Yu P, Li Z, Zhang L, Tagle DA, Cai T (2006) Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 365:111–118PubMedCrossRef

Zsizsik BK, Hardeland R (2002) Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway. Comp Biochem Physiol C Toxicol Pharmacol 133:383–392PubMedCrossRef

Titel: Where does a migraine attack originate? In the brainstem
verfasst von: J. Tajti
D. Szok
Á. Párdutz
B. Tuka
A. Csáti
A. Kuris
J. Toldi
L. Vécsei
Publikationsdatum: 01.05.2012
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 5/2012
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-012-0788-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

Muscarinic acetylcholine receptor-mediated activation of Gq in rat brain membranes determined by guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assay

Why all migraine patients should be treated with magnesium

Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms

The first phase of a migraine attack resides in the cortex

Intra- and inter-cortical motor excitability in Alzheimer’s disease